SCLN Related Analyst Ratings
-
BWS Financial Upgrades SciClone Pharmaceuticals (SCLN) to Buy, Risk Removed
-
Cowen Downgrades SciClone Pharmaceuticals (SCLN) to Neutral
-
Aegis Capital Starts SciClone Pharmaceuticals (SCLN) at Buy
-
Cowen Starts SciClone Pharmaceuticals (SCLN) at Outperform
-
BWS Financial Downgrades SciClone Pharmaceuticals (SCLN) to Hold; SEC Investigation Overhang
-
BWS Financial Maintains Bullish Bias on SciClone Pharmaceuticals (SCLN)
-
BWS Financial Upgrades SciClone Pharmaceuticals (SCLN) to Buy
-
National Securities Initiates Coverage on SciClone Pharmaceuticals (SCLN) with a Buy
-
BWS Financial Downgrades SciClone Pharmaceuticals (SCLN) to Hold; Valuation Call After Recent Run-Up
-
ThinkEquity Initiates Coverage on SciClone (SCLN) with a Buy
-
Susquehanna Maintains a Positive Rating on SciClone Pharmaceuticals (SCLN)
-
Susquehanna Initiates Coverage on SciClone Pharmaceuticals (SCLN) with a Neutral
-
Jefferies Downgraded SCLN
Back to SCLN Stock Lookup
